NCT07128251
- Conditions
- Adenocarcinoma, CTLA-4, Carcinoma, +14 more
- Locations
-
Not specified
Clinical trial condition
PD-1
Explore clinical trials studying PD-1. Study availability and eligibility vary by location and protocol.
16 public trials
9 recruiting studies
PD-1 trial results
Not Yet Recruiting
PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)
NCT07090707
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +8 more
- Locations
-
- Sun yat-sen memorial hospital Guangzhou, Guangdong, China
Not Yet Recruiting
A Prospective Study: the Impact of Sleep Disturbances on Immunotherapy in Patients With Lung Cancer
NCT06953765
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
- Locations
-
Not specified
Not Yet Recruiting
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037
- Conditions
- First-line Therapy, Fruquintinib, GEJ Adenocarcinoma, +3 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
NCT05508399
- Conditions
- Locally Advanced Gastric Adenocarcinoma, PD-1
- Locations
-
- Xijing Hospital of Digestive Diseases Xi'an, Shaanxi, China
Active, Not Recruiting
Tirellizumab Combined With TP Neoadjuvant Therapy in the Treatment of Early Oral Squamous Cell Carcinoma （HNC-SYSU-005）
NCT07267286
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +7 more
- Locations
-
- Sun yat-sen memorial hospital Guangzhou, Guangdong, China